NCT03260569View on ClinicalTrials.gov

Inhaled Nitric Oxide in Brain Injury

PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 12, 2018

Primary Completion Date

December 28, 2023

Study Completion Date

December 28, 2023

Conditions
Traumatic Brain Injury
Interventions
DRUG

Inhaled Nitric Oxide

Patients randomized to this arm will receive inhaled nitric oxide 20 parts per million.

DRUG

Placebo

Nitrogen plus oxygen

Trial Locations (1)

45267

University of Cincinnati, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER

NCT03260569 - Inhaled Nitric Oxide in Brain Injury | Biotech Hunter | Biotech Hunter